Reagent Kit for Detecting HIV-1 Drug Resistance Mutations by PCR with Subsequent Massively Parallel Sequencing "AmpliSens® HIV-Resist-NGS"

This reagent kit is designed for identifying mutations associated with resistance of human immunodeficiency virus type 1 (HIV-1) to antiretroviral drugs in biological samples using polymerase chain reaction (PCR) followed by next-generation sequencing (NGS) of amplification products, in accordance with TU 9398-240-01897593-2015.

Available Configurations:

Form 1 Includes:

"RIBO-zol-E" – 1 pc.
RNA Stabilization Kit – 1 pc.
OT-PCR Kit HIV-NGS – 1 pc.
PCR Kit HIV-NGS – 1 pc.
EF NGS – 2 pcs.
Library Preparation Kit – 1 pc.
Library Indexing Kit – 1 pc.
Library Normalization and Quality Assessment Kit – 1 pc.
Library Concentration Assessment Kit – 1 pc.
Massively Parallel Sequencing Kit, v2-500 – 1 pc.
"DEONA NGS" Software Package – 1 pc.

Form 2 Includes:

"RIBO-zol-E" – 1 pc.
RNA Stabilization Kit – 1 pc.
OT-PCR Kit HIV-NGS – 1 pc.
PCR Kit HIV-NGS – 1 pc.
EF NGS – 2 pcs.
Library Preparation Kit – 1 pc.
Library Indexing Kit – 1 pc.
Library Normalization and Quality Assessment Kit – 1 pc.
Library Concentration Assessment Kit – 1 pc.
Massively Parallel Sequencing Kit, v3-600 – 1 pc.
"DEONA NGS" Software Package – 1 pc.

Form 3 Includes:

"RIBO-zol-E" – 1 pc.
RNA Stabilization Kit – 1 pc.
OT-PCR Kit HIV-NGS – 1 pc.
PCR Kit HIV-NGS – 1 pc.
EF NGS – 2 pcs.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Detecting HIV-1 Drug Resistance Mutations by PCR with Subsequent Massively Parallel Sequencing "AmpliSens® HIV-Resist-NGS", then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back